期刊文献+

MMP-3在结直肠腺瘤及结直肠癌中的表达与临床意义的相关性研究

MMP-3 in colorectal adenoma and colorectal carcinoma and clinicopathologic correlation study
下载PDF
导出
摘要 目的探讨基质金属蛋白酶MMP-3在结直肠腺瘤及结直肠癌中表达与临床病理参数间相关性。方法应用免疫组织化学方法检测MMP-3在20例结直肠腺瘤和60例结直肠癌中的表达。结果 MMP-3在20例结直肠腺瘤及60例结直肠癌中,阳性表达率分别为10%、41.7%(P=0.031)。MMP-3的阳性表达与淋巴结转移(P=0.017)呈正相关,与预后呈负相关。结论 MMP-3的上调表达可能参与了结直肠癌的发生、发展、浸润及转移,对临床上判断预后具有较大意义。 Objective To explore the matrix metalloproteinases MMP-3 in colorectal adenoma and colorectal carcinoma with clinicopathological parameters of correlation.Methods Immunohistochemistry was used to detect MMP-3 in 20 cases of colorectal adenoma and 60 cases of colorectal carcinoma.Results The positive expression rates of MMP-3 in 20 cases of colorectal adenoma and 60 cases of colorectal cancer were 10% and 41.7% (P =0.031 ).The expression of MMP-3 (P =0.017)were positively correlated with lymph node metastasis,and negatively correlated with the prognosis.Conclusion Upregulation of MMP-3 expression may be involved in the incidence of colorectal cancer development,invasion and metastasis,and it has great significances for the clinical prognosis.
作者 鲁明良 何瑾
出处 《结直肠肛门外科》 2014年第4期232-234,共3页 Journal of Colorectal & Anal Surgery
关键词 结直肠腺瘤 结直肠癌 MMP-3 Colorectal adenoma Colorectal carcinoma MMP-3
  • 相关文献

参考文献4

二级参考文献20

  • 1Brink M, de Goeij A F, Weijenberg M P, et al. K - rasoncogene mutations in sporadic colorectal cancer in the Netherlands cohort study[ J]. Carcinogenesis,2003,24 (4) :703 - 710.
  • 2Wang J Y, Wang Y H, Jao S W, et al. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas : correlation to activated K - ras oncogene [J]. Oncology Reports,2006,16 ( 6 ) : 1245 - 1252.
  • 3Akino K, Toyota M, Suzuki H, et al. The Ras effector RASSF2 is a novel tumor - suppressor gene in human colorectal cancer [ J ]. Gastroenterology ,2005,129 ( 1 ) :156 - 169.
  • 4Hesson L B,Wilson R,Morton D,et al. CpG island promoter hyper - methylation of a novel Ras - effector gene RASSF'2A is an early event in colon carcinogenesis and correlates inversely with K - ras mutations[J]. Oncogene,2005,.24(24) :3987 - 3994.
  • 5Laurent E, McCoy J W, Macina R A, et al. Noxl is over - expressed in human colon cancers and correlates with activating mutations in K - ras[ J]. International Journal of Cancer,2008, 123(1) :100 - 107.
  • 6Pajkos G, Kiss I, Sandor J, et al. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K - ras oncogene in colorectal cancer[ J ]. Anti cancer Research ,2000,20 (3A) :1695 - 1701.
  • 7Ieda S,Watatani M,Yoshida T,et al. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas amd early carcinomas[J]. Surgery Today,1996,26(4) :230 - 235.
  • 8Zavodna K, Konecny M, Krivulcik T, et al. Genetic analysis of K - ras mutation status in metastatic colorectal cancer patients[J]. Neoplasma,2009,56 ( 3 ) :275 - 278.
  • 9Georgieva M, Krasteva M, Angelova E, et al. Analysis of the K -ras/B - raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients [ J ]. Oncology Reports,2008,20(1 ) :3 - 11.
  • 10Halatsch M E, Hirsch - Ernst K I, Weinel R J, et al. Differential activation of the c - Ki - ras - 2 proto - oncogene in human colorectal carcinoma [ J ]. Anticancer Research, 1998,18 ( 4A ) : 2323 - 2325.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部